EVENT
【Seminar】WPI-Bio2Q Open Seminar: Min Xu, Ph.D.
May 13, 2025
Min Xu, Ph.D.
Credits: WPI-Bio2Q
With Dr. Min Xu at the venue
Credits: WPI-Bio2Q
Poster
Credits: WPI-Bio2Q
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held a seminar as follows.
| Date & Time | April 24, 2025, 14:00 -16:40 |
|---|---|
| Venue | JKiC, Shinanomachi Campus, Keio University |
| ①Talk | Advancing Biomedical Image Analysis and Lab Automation through Computer Vision |
| Speaker | Min Xu, Ph.D., Associate Professor, Computational Biology, School of Computer Science, Carnegie Mellon University |
| ②Deep Dive Session | Automation in structural biology imaging |
| Chair | Takahiko Koyama(Project Professor, Keio University Bio2Q / Quantum Computing, Artificial Intelligence in Life Sciences) |
| Abstract | Recent breakthroughs in computer vision have significantly transformed biomedical image analysis, providing sophisticated tools to interpret complex biological phenomena and streamline laboratory workflows. In this talk, I will present my lab’s contributions to developing and applying cutting-edge computer vision techniques, with a particular emphasis on cryo-electron tomography (cryo-ET). Cryo-ET al allows researchers to visualize cellular structures at a sub-molecular resolution within their natural contexts, and our novel approaches have facilitated the analysis and interpretation of these intricate imaging datasets. Additionally, I will discuss our ongoing efforts to leverage computer vision in lab automation, which may accelerate experimental efficiency, reproducibility, and biological discovery. Overall, our advancements in computer vision are helping bridge state-of-the-art imaging technologies with automated laboratory systems, potentially enhancing biomedical research capabilities and enabling deeper insights into biological systems. |
More Bio2Q News
【Nov. 25 Seminar】 WPI-Bio2Q Open Seminar: Xu Zhang, PhD(for Keio Members)
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This event is only for faculty, students, and staff of Keio University. Date and Time Wednesday, November 25, 2026, 11:00-11:40 Format Zoom (Online only) Title Senescent Cell–Derived Factors Suppress Innate Antiviral Immunity During Aging Speaker Xu Zha...
【Event Report】Bio2Q Participates in the 15th WPI Science Symposium, Engaging wit...
On Saturday, November 14, 2026, the 15th WPI Science Symposium, themed “World Premieres Born from Me! ~Science I Want to Share with Someone~,” was held at the Osaka University Convention Center in Suita, Osaka, hosted by the Osaka University Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe). The event featured a special lecture by Prof. Shimon Sakaguchi (Distinguished University ...
WPI-Bio2Q now recruiting administrative staff– Deadline: January 11, 2027
WPI-Bio2Q Administrative Office is currently hiring administrative staff. We look forward to receiving applications from candidates with English proficiency who can support international researchers and anticipate to work at Bio2Q Administrative Office. Application Deadline: January 11, 2027 For more details, please refer to the application information at the link below, Application Info...
New Long-Term Internship Student-Mr. Kevin Deesy
Introducing a new Long-Term Internship Student of Bio2Q We are delighted to welcome Mr. Kevin Deesy as a new Long-Term Research Internship Student of Bio2Q. "Hello Bio2Q team, My name is Kevin Deesy, and I’m currently completing my Master’s in Sustainable Food at the Technical University of Munich (TUM), specializing in molecular biotechnology and microbiology. My research so far has take...
New Member - Dr. Augustinas Silale
Introducing new member of Bio2Q We are excited to welcome Dr. Augustinas Silale as a Jr. PI at Bio-2 Core of Bio2Q. "Hello, Bio2Q community! My name is Augustinas (August) Silale. I am from Lithuania. I am delighted to join Bio2Q as a Jr. PI. I read Natural Sciences at the University of Cambridge. My BA project was on fragment-based drug discovery in Prof Sir Tom Blundell’s group, where ...

